Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
04/07/1992 | US5102790 Method for culturing animal cells |
04/07/1992 | CA1298551C Extracellular matrix induction method to produce pancreatic islet tissue |
04/06/1992 | WO1992006178A1 Megakaryocyte and platelet growth, production and composition |
04/06/1992 | WO1992006177A1 Method for enzymatic regeneration of cell culture media and kits therefor |
04/06/1992 | WO1992005698A1 Regulation of immunoglobulin production by interleukin-9 |
04/06/1992 | CA2092413A1 Method for enzymatic regeneration of cell culture media and media kits therefor |
04/06/1992 | CA2069879A1 Megakaryocyte and platelet growth, production and composition |
04/06/1992 | CA2052808A1 Virus-resistant plants and their production |
04/03/1992 | CA2052501A1 Monoclonal antibodies directed against complexes formed by thrombin and thrombin inhibitors |
04/02/1992 | WO1992006218A1 A novel onco-fetal gene, gene product and uses therefor |
04/02/1992 | WO1992006197A1 Method of testing for salmonella |
04/02/1992 | WO1992006180A1 Targeting viruses and cells for selective internalization by cells |
04/02/1992 | WO1992005262A1 Methods and compositions for genetic therapy and potentiation of anti-tumor immunity |
04/02/1992 | WO1992005259A1 Transgenic plants having a modified carbohydrate content |
04/02/1992 | WO1992005256A1 Natural killer stimulatory factor |
04/02/1992 | WO1992005251A1 Dna sequence imparting cytoplasmic male sterility, mitochondrial genome, nuclear genome, mitochondria and plant containing said sequence and process for the preparation of hybrids |
04/02/1992 | WO1992005247A1 Media for culture of insect cells |
04/02/1992 | WO1992005246A1 Medium for culture of mammalian cells |
04/02/1992 | WO1992005193A1 Plasmodium liver stage antigens |
04/02/1992 | WO1992005184A1 A non-mitogenic competitive hgf antagonist |
04/02/1992 | WO1991018047A3 Mammalian expression of the bmp-2 family |
04/02/1992 | DE4132746A1 Cloning of cells producing a specific prod. - using a selective latex binding and staining technique |
04/02/1992 | CA2092920A1 Aprotinin analogues |
04/02/1992 | CA2092916A1 Onco-fetal gene, gene product and uses therefor |
04/02/1992 | CA2092323A1 Targeting viruses and cells for selective internalization by cells |
04/02/1992 | CA2091982A1 Method of testing for salmonella |
04/02/1992 | CA2091443A1 Medium for culture of mammalian cells |
04/01/1992 | EP0478366A2 Recombinant hybrid immunoglobulin molecules and method of use |
04/01/1992 | EP0478272A2 Gp98 cell adhesion molecule and integrin complex containing it |
04/01/1992 | EP0478017A1 Monoclonal antibody with specificity for human myosin light chains |
04/01/1992 | EP0477994A1 Parasite-derived resistance |
04/01/1992 | EP0477739A2 Glycosyl-Phosphatidylinositol-Specific Phospholipase D |
04/01/1992 | EP0477307A1 Superantigen induced immune non-responsiveness |
04/01/1992 | EP0477290A1 Methods, compositions and devices for growing cells. |
04/01/1992 | EP0477269A1 Pharmaceutical compositions and methods of treatment using alzheimer's amyloid polypeptides |
04/01/1992 | EP0477226A1 Contraceptive vaccine based on cloned zona pellucida gene |
03/31/1992 | US5100799 With a trypsin solution |
03/31/1992 | US5100783 Weighted microsponge for immobilizing bioactive material |
03/31/1992 | US5100676 Storage stable wound dressing with colonies of keratinocytes, skin grafts |
03/31/1992 | EP0555203A4 Expression induction method employing mutant dhfr gene. |
03/31/1992 | CA1298220C Immortalized human cell lines |
03/29/1992 | WO1992006201A1 Glyphosate-tolerant 5-enolpyruvyl-3-phosphoshikimate synthases |
03/29/1992 | WO1992006116A1 Hybrid growth factors |
03/29/1992 | CA2090617A1 Glyphosate-tolerant 5-enolpyruvyl-3-phosphoshikimate synthases |
03/29/1992 | CA2069746A1 Hybrid growth factors |
03/28/1992 | WO1992006205A1 A process for the gene manipulation of plant cells, recombinant plasmids, recombinant bacteria, plants |
03/28/1992 | CA2089072A1 Process for the gene manipulation of plant cells, recombinant plasmids, recombinant bacteria, plants |
03/28/1992 | CA2052283A1 Recombinant hybrid immunoglobulin molecules and method of use |
03/27/1992 | CA2026229A1 Use of feedback control for the continuous phasing of cell culture |
03/25/1992 | WO1992005286A1 Screening assays |
03/25/1992 | EP0476983A1 Vascular endothelial cell growth factor II |
03/25/1992 | EP0476946A2 Single stage avian embryo culture process |
03/25/1992 | EP0476226A1 Monoclonal antibody against human IgE |
03/25/1992 | EP0476093A1 Production of improved rapeseed exhibiting a reduced saturated fatty acid content. |
03/25/1992 | EP0476018A1 Introduction of bacteria in ovo |
03/25/1992 | EP0475972A1 Improved culture of human tumor-infiltrating lymphocytes by combining gas permeable bags and a primary culture container |
03/25/1992 | EP0475961A1 Generation and expansion of lak cells |
03/25/1992 | EP0218713B1 High yield production of active factor ix |
03/25/1992 | CA2092000A1 Screening assays |
03/25/1992 | CA2051749A1 Cell adhesion molecule |
03/25/1992 | CA2050817A1 Hiv-neutralizing rat monoclonal antibodies against pb-1 |
03/24/1992 | US5098842 Medium, apparatus and method for cell separation |
03/24/1992 | US5098829 Immunoadsorbents |
03/24/1992 | CA1297823C Somatic embryogenesis employing organic acids |
03/24/1992 | CA1297819C Hybridoma tumor cell lines and their monoclonal antibodies to theumatin |
03/24/1992 | CA1297817C Monoclonal antibody specific to a common determinant site of neutrophilsand eosinophils |
03/24/1992 | CA1297816C Platelet function inhibiting monoclonal antibody fragment |
03/24/1992 | CA1297815C Fibrinogen blocking monoclonal antibody |
03/22/1992 | WO1992005266A2 Packaging cells |
03/22/1992 | CA2051796A1 Vascular endothelial cell growth factor ii |
03/19/1992 | WO1992005273A1 Gene therapy for cystic fibrosis |
03/19/1992 | WO1992004449A1 Glyphosate tolerant 5-enolpyruvylshikimate-3-phosphate synthases |
03/19/1992 | WO1992004446A1 Cloning of chicken anaemia dna |
03/19/1992 | WO1992004378A1 Recombinant agents affecting thrombosis |
03/19/1992 | WO1992004033A1 Methods for inhibiting rejection of transplanted tissue |
03/19/1992 | WO1992003918A1 Transgenic non-human animals capable of producing heterologous antibodies |
03/19/1992 | WO1992003917A1 Homologous recombination in mammalian cells |
03/19/1992 | WO1992002612A3 Tissue plasminogen activator variants with decreased clearance |
03/19/1992 | WO1991018981A3 Neurotropic growth factors comprising a homeobox peptide |
03/19/1992 | DE4029227A1 Arzneimittel enthaltend cd14 Medicines containing CD14 |
03/19/1992 | CA2090473A1 Homologous recombinatin in mammalian cells |
03/19/1992 | CA2090410A1 Antithrombosis agents |
03/18/1992 | WO1992005265A1 Recombinant baculoviral vectors using early promotors |
03/18/1992 | EP0475746A1 Human and murine interleukin-5 receptor |
03/18/1992 | EP0475584A2 Inactivation of gene transcription in plants using altered transcriptional activators |
03/18/1992 | EP0475354A2 Sialysation of glycoproteins by genetic technology |
03/18/1992 | EP0475303A2 Growth of cells in hollow fibers in an agitated vessel |
03/18/1992 | EP0474901A1 Method of culturing bupleurum protoplast |
03/18/1992 | EP0474846A1 Polypeptides with a dopaminergic receptor activity, nucleic acids coding for these polypeptides and use of these polypeptides to screen active substances on these polypeptides. |
03/18/1992 | EP0474783A1 Vpt protein, vectors expressing this protein, cell products and assay methods |
03/18/1992 | EP0243397B1 Process for separating motile sperm cells in vitro, fertilization method and penetration medium for sperm cells |
03/18/1992 | CA2091887A1 Use of baculovirus early promoters for expression of foreign genes in stably transformed insect cells or recombinant baculoviruses |
03/18/1992 | CA2051303A1 Single stage avian embryo culture process |
03/17/1992 | US5096822 Containing nutrients including hemicalcium lactate; genetic engineering, cloning |
03/17/1992 | US5096816 Increasing production of terminally sialylated secreted monoclonal antibody in an ammonia cell culture by growing the cells at a pH of 7.2-7.4, gradually decreasing pH to 6.7-7.05 and maintaining during production phase, harvesting |
03/17/1992 | CA1297436C Eucaryotic expression system |
03/17/1992 | CA1297435C Messenger rna stabilization in animal cells |
03/17/1992 | CA1297434C Method of producing peptides, recombinant plasmid for use in the same and animal cells transformed with the same |
03/17/1992 | CA1297293C Process for regenerating corn |
03/15/1992 | WO1992004908A1 Drug containing cd14 |